Which super funds hold CRISPR Therapeutics AG?
As at 31 December 2025, 10 Australian super investment options in our dataset held CRISPR Therapeutics AG, the largest weighting being 0.05% in International Shares (Accumulation) (AustralianSuper).
Options holding it
10
Largest weighting
0.05%
International Shares (Accumulation) · AustralianSuper
Australian super investment options disclosing a holding in CRISPR Therapeutics AG. Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.
| Fund | Phase | Option | Weighting | Value (AUD) | As at |
|---|---|---|---|---|---|
| AustralianSuper | Accumulation | Balanced (Accumulation) | 0.02% | $45,271,098 | 31 December 2025 |
| AustralianSuper | Accumulation | High Growth (Accumulation) | 0.02% | $10,165,227 | 31 December 2025 |
| AustralianSuper | Retirement | Balanced (Income) | 0.02% | $5,995,383 | 31 December 2025 |
| AustralianSuper | Accumulation | International Shares (Accumulation) | 0.05% | $5,321,672 | 31 December 2025 |
| AustralianSuper | Retirement | Conservative Balanced (Income) | 0.01% | $1,242,774 | 31 December 2025 |
| AustralianSuper | Accumulation | Conservative Balanced (Accumulation) | 0.01% | $1,025,075 | 31 December 2025 |
| AustralianSuper | Retirement | International Shares (Income) | 0.05% | $792,547 | 31 December 2025 |
| AustralianSuper | Retirement | High Growth (Income) | 0.02% | $687,883 | 31 December 2025 |
| AustralianSuper | Accumulation | Stable (Accumulation) | 0.01% | $428,738 | 31 December 2025 |
| AustralianSuper | Retirement | Stable (Income) | 0.01% | $394,922 | 31 December 2025 |
This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.
Methodology — how holdings are sourced, resolved and aggregated.